Compare GOTU & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GOTU | PACB |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 607.6M | 682.3M |
| IPO Year | 2019 | 2010 |
| Metric | GOTU | PACB |
|---|---|---|
| Price | $2.12 | $1.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $2.08 |
| AVG Volume (30 Days) | 477.6K | ★ 8.0M |
| Earning Date | 03-05-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $821,732,499.00 | $160,005,000.00 |
| Revenue This Year | $36.79 | $4.64 |
| Revenue Next Year | $15.97 | $12.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 49.01 | 3.89 |
| 52 Week Low | $2.06 | $0.85 |
| 52 Week High | $4.56 | $2.73 |
| Indicator | GOTU | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 43.63 |
| Support Level | $2.06 | $1.72 |
| Resistance Level | $2.34 | $1.90 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 14.29 | 25.04 |
Gaotu Techedu Inc is a technology-driven education company that provides online live courses in a large-class setting backed by its proprietary technology infrastructure. The company offers courses in large-class format, which amplifies the benefits of online education and allows it to rapidly expand its student base. It operates solely in the PRC and all assets are located in the PRC. The learning services that the company offers include Traditional Learning Services, Non-Academic Tutoring Services, and College Student and Adult Education Services. It derives maximum revenue from Learning Services and also from Educational content & digitalized learning products.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.